Exosome‐based engineered IL‐10 mRNA offers an efficient drug delivery vector target to macrophages in plaques of experimental atherosclerosis and alleviates atherosclerosis in ApoE−/− mice. This evidence concerns the gene IL10 and atherosclerosis.